Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.

ondansetron ultra-low dose (AD04) - Adial

http://www.ncbi.nlm.nih.gov/pubmed/38876929

Bankole Johnson; Giovanni Addolorato; Hannu Alho; Jonathan Chick; Lei Liu; Otto Michael Lesch; Vinzant Schuyler

Jun 15, 2024